CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1475-2867
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis ; volume:21 ; number:1 ; day:4 ; month:12 ; year:2021 ; pages:1-16 ; date:12.2021
Cancer cell international ; 21, Heft 1 (4.12.2021), 1-16, 12.2021

Creator
Kong, Haoran
Yu, Wenhui
Chen, Zhuning
Li, Haonan
Ye, Guiwen
Hong, Jiacong
Xie, Zhongyu
Chen, Keng
Wu, Yanfeng
Shen, Huiyong
Contributor
SpringerLink (Online service)

DOI
10.1186/s12935-021-02320-0
URN
urn:nbn:de:101:1-2022020719422103514601
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:35 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Kong, Haoran
  • Yu, Wenhui
  • Chen, Zhuning
  • Li, Haonan
  • Ye, Guiwen
  • Hong, Jiacong
  • Xie, Zhongyu
  • Chen, Keng
  • Wu, Yanfeng
  • Shen, Huiyong
  • SpringerLink (Online service)

Other Objects (12)

Correction to: CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis

Correction to: CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis

Toosendanin inhibits adipogenesis by activating Wnt/β-catenin signaling

Toosendanin inhibits adipogenesis by activating Wnt/β-catenin signaling

NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling

NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling

Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling

Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling

LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation

LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation

TGM2 accelerates migration and differentiation of BMSCs by activating Wnt/β-catenin signaling

TGM2 accelerates migration and differentiation of BMSCs by activating Wnt/β-catenin signaling

DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway

DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway

AF1q Contributes to Adriamycin-Induced Podocyte Injury by Activating Wnt/β-Catenin Signaling

AF1q Contributes to Adriamycin-Induced Podocyte Injury by Activating Wnt/β-Catenin Signaling

FOXH1 promotes lung cancer progression by activating the Wnt/β-catenin signaling pathway

FOXH1 promotes lung cancer progression by activating the Wnt/β-catenin signaling pathway

Retraction Note: Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt/β-catenin signaling pathway

Retraction Note: Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt/β-catenin signaling pathway

UCHL5 promotes hepatocellular carcinoma progression by promoting glycolysis through activating Wnt/β-catenin pathway

UCHL5 promotes hepatocellular carcinoma progression by promoting glycolysis through activating Wnt/β-catenin pathway

MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/β-Catenin Signaling

MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/β-Catenin Signaling

Related objects